Atlas Trials

Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder

Clinical trial NCT00277654 · COMPLETED

Trial details

NCT number
NCT00277654
Sponsor
Lindner Center of HOPE
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar DisorderAnxiety Disorder
Start date
2004-02-01
Primary completion
2009-03-01
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.